THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia

Not Applicable

Completed

Conditions: Trigeminal Neuralgia

Interventions: Drug: Placebo
Drug: lamotrigine

First Posted Date: 2005-09-20

Last Posted Date: 2014-06-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT00203229

Locations: 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States

Preventing Depression in Patients With Macular Degeneration

Phase 3

Completed

Conditions: Depression
Macular Degeneration

Interventions: Behavioral: Problem Solving Treatment
Behavioral: Control

First Posted Date: 2002-07-26

Last Posted Date: 2014-01-08

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 206

Registration Number: NCT00042211

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

GM1 Ganglioside Effects on Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson Disease

Interventions: Drug: Placebo
Drug: GM1 ganglioside

First Posted Date: 2002-05-23

Last Posted Date: 2012-12-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 94

Registration Number: NCT00037830

Locations: 🇺🇸
Parkinson's Disease Research Unit, Thomas Jefferson University, Philadelphia, Pennsylvania, United States

The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

Phase 3

Completed

Conditions: Turner Syndrome

Interventions: Drug: estrogen
Drug: androgen
Other: placebo

First Posted Date: 2002-01-09

Last Posted Date: 2012-06-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 200

Registration Number: NCT00029159

Locations: 🇺🇸
Thomas Jefferson University Hospital, 1025 Walnut Street, Suite 726, Philadelphia, Pennsylvania, United States
🇺🇸
National Institutes of Health, Bethesda, Maryland, United States

Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

Phase 2

Completed

Conditions: Anemia
HIV Infections
Acquired Immunodeficiency Syndrome
Hematologic Diseases
Blood Disease

First Posted Date: 1999-10-28

Last Posted Date: 2021-11-26

Lead Sponsor: Thomas Jefferson University

Registration Number: NCT00000587

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy